Low dose desensitisation does not reduce the toxicity of sulphasalazine in rheumatoid arthritis.
OBJECTIVE: To examine the proposal that pretreatment low dose desensitisation may reduce the incidence of toxicity of sulphasalazine in the treatment of rheumatoid arthritis (RA). METHODS: A double blind, placebo controlled trial was performed with 422 patients satisfying the American College of Rhe...
Na minha lista:
| Udgivet i: | Ann Rheum Dis |
|---|---|
| Principais autores: | , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BMJ Publishing Group
1996
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC1010172/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8660109/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/ard.55.5.328 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
